Sartorius Stedim Biotech SA - Asset Resilience Ratio

Latest as of June 2025: 0.55%

Sartorius Stedim Biotech SA (DIM) has an Asset Resilience Ratio of 0.55% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€45.80 Million
Cash + Short-term Investments

Total Assets

€8.31 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2024)

This chart shows how Sartorius Stedim Biotech SA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Sartorius Stedim Biotech SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €45.80 Million 0.55%
Total Liquid Assets €45.80 Million 0.55%

Asset Resilience Insights

  • Limited Liquidity: Sartorius Stedim Biotech SA maintains only 0.55% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sartorius Stedim Biotech SA Industry Peers by Asset Resilience Ratio

Compare Sartorius Stedim Biotech SA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Unicon Optical Co., Ltd.
TWO:4150
Medical Instruments & Supplies 2.00%
Pegavision
TW:6491
Medical Instruments & Supplies 17.14%
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
Medical Instruments & Supplies 0.06%
Blue Sail Medical Co Ltd
SHE:002382
Medical Instruments & Supplies 5.12%
Andon Health Co Ltd
SHE:002432
Medical Instruments & Supplies 35.75%
Allmed Medical Products Co Ltd Class A
SHE:002950
Medical Instruments & Supplies 3.78%
Inix Technologies Holdings Bhd
KLSE:0094
Medical Instruments & Supplies 0.06%
Focus Point Holdings Bhd
KLSE:0157
Medical Instruments & Supplies 2.30%

Annual Asset Resilience Ratio for Sartorius Stedim Biotech SA (2008–2024)

The table below shows the annual Asset Resilience Ratio data for Sartorius Stedim Biotech SA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.12% €9.90 Million €8.26 Billion 0.00pp
2023-12-31 0.12% €9.50 Million €7.74 Billion -0.39pp
2022-12-31 0.51% €25.90 Million €5.07 Billion +0.16pp
2021-12-31 0.35% €13.72 Million €3.95 Billion +0.03pp
2020-12-31 0.32% €9.84 Million €3.07 Billion -0.68pp
2019-12-31 1.01% €18.30 Million €1.82 Billion -0.22pp
2018-12-31 1.22% €19.21 Million €1.57 Billion +0.31pp
2017-12-31 0.91% €12.84 Million €1.40 Billion +0.22pp
2016-12-31 0.69% €8.27 Million €1.20 Billion -0.09pp
2015-12-31 0.78% €8.35 Million €1.07 Billion +0.03pp
2014-12-31 0.75% €6.79 Million €906.76 Million -0.02pp
2013-12-31 0.77% €6.70 Million €871.23 Million +0.90pp
2012-12-31 -0.13% €-1.05 Million €793.87 Million +0.13pp
2008-12-31 -0.26% €-1.69 Million €652.34 Million --
pp = percentage points

About Sartorius Stedim Biotech SA

PA:DIM France Medical Instruments & Supplies
Market Cap
$21.46 Billion
€18.36 Billion EUR
Market Cap Rank
#1319 Global
#28 in France
Share Price
€188.70
Change (1 day)
+3.57%
52-Week Range
€160.15 - €223.00
All Time High
€542.33
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more